SCHEMBL19977149

SCHEMBL19977149

CC(C)c1c[nH]c2cc(CC(C)c3ccccc3)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
CYP2D6 P10635 1/20 0.43
KCNH2 Q12809 1/20 0.43
HTR2A P28223 3/20 0.42
HTR2C P28335 3/20 0.42
HTR2B P41595 3/20 0.42
GPR84 Q9NQS5 3/20 0.41
FFAR1 O14842 2/20 0.39
SRC P12931 1/20 0.38
MAOA P21397 3/20 0.38
MAOB P27338 3/20 0.38
NISCH Q9Y2I1 3/20 0.38
NR3C1 P04150 2/20 0.37
NR3C2 P08235 2/20 0.37
PGR P06401 1/20 0.37
AR P10275 1/20 0.37
MGAM O43451 3/20 0.37
GAA P10253 3/20 0.37
SI P14410 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22623758 0.79 HTR2A (0.42) SLC6A2SLC6A4CYP2D6KCNH2HTR2A
SCHEMBL9006921 0.77 KIF11 (0.45) HTR2AHTR2CHTR2BGPR84FFAR1
SCHEMBL20078216 0.77 HTR2A (0.35) SLC6A2SLC6A4HTR2AHTR2CHTR2B
SCHEMBL18853764 0.76 HTR2A (0.45) SLC6A2SLC6A4HTR2AHTR2CHTR2B
SCHEMBL20695516 0.76 HTR2A (0.38) SLC6A2SLC6A4CYP2D6HTR2AHTR2C
SCHEMBL888682 0.72 KIF11 (0.49) SLC6A2SLC6A4CYP2D6KCNH2HTR2A
SCHEMBL23978973 0.72 ESR1 (0.47) SLC6A2CYP2D6HTR2AHTR2BNR3C1
SCHEMBL21361280 0.72 PNMT (0.41) HTR2AHTR2CHTR2BMAOAMAOB
SCHEMBL20892518 0.72 MDM2 (0.36) HTR2AHTR2CHTR2BADRA2A
SCHEMBL23102828 0.71 IMPDH2 (0.61) SLC6A4MAOAHTR1DMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265173-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES ZYMEWORKS BC INC. (CA) 2023-08-24 US disclosed
US-9918473-B2 Use of aryl carbamates in agriculture and other plant-related areas North Carolian State University (US) 2018-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265173-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES MPST, TPST2, SULT1A1 SLC6A2 413/4885SLC6A4 747/4885CYP2D6 639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.